Distinct contribution of IL-6, TNF-alpha, IL-1, and IL-10 to T cell-mediated spontaneous autoimmune arthritis in mice.
about
Regulation of adaptive immunity; the role of interleukin-10TocilizumabReview: is there a window of opportunity for treatment of systemic juvenile idiopathic arthritis?Combined anti-tumor necrosis factor-α therapy and DMARD therapy in rheumatoid arthritis patients reduces inflammatory gene expression in whole blood compared to DMARD therapy aloneEvidence for an anti-inflammatory loop centered on polymorphonuclear leukocyte formyl peptide receptor 2/lipoxin A4 receptor and operative in the inflamed microvasculature.Investigation of the relationship between the onset of arthritis and uveitis in genetically predisposed SKG miceModulation of IL-17 and Foxp3 expression in the prevention of autoimmune arthritis in miceInflammation and transplantation tolerance.Cytokines secreted in response to Toll-like receptor ligand stimulation modulate differentiation of human Th17 cellsCD4+CD25+ regulatory T cells in autoimmune arthritis.Neuroinflammation in pulmonary hypertension: concept, facts, and relevance.Interleukin-1β and interleukin-6 in arthritis animal models: roles in the early phase of transition from acute to chronic inflammation and relevance for human rheumatoid arthritisCytokine-dependent but acquired immunity-independent arthritis caused by DNA escaped from degradation.Bone formation and resorption are both increased in experimental autoimmune arthritis.Matrix metalloproteinase-8 deficiency increases joint inflammation and bone erosion in the K/BxN serum-transfer arthritis model.Interleukin 6 in autoimmune and inflammatory diseases: a personal memoirIL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trialSystemic but no local effects of combined zoledronate and parathyroid hormone treatment in experimental autoimmune arthritis.The impact of inflammation on bone mass in children.Glycogen synthase kinase-3 controls IL-10 expression in CD4(+) effector T-cell subsets through epigenetic modification of the IL-10 promoter.Interactions between IL-32 and tumor necrosis factor alpha contribute to the exacerbation of immune-inflammatory diseases.Cells of the synovium in rheumatoid arthritis. T lymphocytes.The T cell cometh: interplay between adaptive immunity and cytokine networks in rheumatoid arthritis.TCRzetadim lymphocytes define populations of circulating effector cells that migrate to inflamed tissuesAutoimmune arthritis associated with mutated interleukin (IL)-6 receptor gp130 is driven by STAT3/IL-7-dependent homeostatic proliferation of CD4+ T cells.Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model.Tumor necrosis factor inhibitor therapy for rheumatoid arthritis.A role for fungal {beta}-glucans and their receptor Dectin-1 in the induction of autoimmune arthritis in genetically susceptible mice.Increased toll-like receptor 2 expression in peptidoglycan-treated blood monocytes is associated with insulin resistance in patients with nondiabetic rheumatoid arthritis.Inflammatory arthritis increases mouse osteoclast precursors with myeloid suppressor functionInterleukin-6 in aging and chronic disease: a magnificent pathwayNovel therapies for rheumatoid arthritis.Rheumatoid and pyrophosphate arthritis synovial fibroblasts induce osteoclastogenesis independently of RANKL, TNF and IL-6.Increased responsiveness to toll-like receptor 4 stimulation in peripheral blood mononuclear cells from patients with recent onset rheumatoid arthritis.Developments in the synovial biology field 2006.Arthritis augments breast cancer metastasis: role of mast cells and SCF/c-Kit signalingEpigallocatechin-3-gallate inhibits IL-6 synthesis and suppresses transsignaling by enhancing soluble gp130 production.Therapeutic antibodies that target inflammatory cytokines in autoimmune diseasesLoss of the Protein Tyrosine Phosphatase PTPN22 Reduces Mannan-Induced Autoimmune Arthritis in SKG Mice.Evaluation of anti-IL-6 monoclonal antibody therapy using murine type II collagen-induced arthritis.
P2860
Q21131215-603B1D2B-FD5E-47D1-B31A-74031B80B77AQ24655317-C4749BC0-B374-4C19-B141-43667F39ABD0Q27002805-DF01B9C4-53D3-44A6-86FD-E35BE2B83D89Q28710288-1870FF50-CF61-4BD6-8153-74128F608366Q30504456-B0784202-2456-4D7B-A000-D798FCD146B6Q30661980-1D308E27-EF03-4F5C-BA1F-58173D864497Q30982756-542BCCFB-8382-46F3-BC15-EF0AE773ED61Q33823699-3D35686C-FC7C-4FB9-AB1B-3FD30CF00738Q34011616-46BEC3DD-615E-4D4B-B9E9-0B1C4D5C60F2Q34012863-5FCE32C4-3C4B-413D-80A9-FFC2D1DE9DD1Q34205701-ECEA79CA-AF24-4EE8-B6FE-FF676354ADDBQ34274249-3304E1B3-5B87-4513-9BB8-2FB5F85CBF1AQ34320329-25192B70-E417-42F1-AFFA-8AE33DC20999Q34541587-E5217346-4C1B-4E7D-990B-0B8664D2D0C5Q34614073-F1387DA2-2A62-4164-AE26-68FB0A57F88BQ34734696-D8BC5692-782C-41D9-B57D-E82F8B20291AQ34795777-192FE0E1-92D0-4E20-AA89-976FA5C2DD44Q35122997-E78803B5-0C51-4593-8B36-E0060C623270Q35226354-E6177C23-0F6A-49CA-B7E6-4C426152C2AFQ35509305-354F379E-6E20-4ECD-9F65-527C765E8714Q35630027-EE401485-8E5A-4CBF-B2D6-B42A5B17C4BDQ35769049-66003043-90F3-4617-9901-99B7C8888132Q35864869-E5E44313-1BBC-4219-9CDF-686DDE1244B8Q35924790-CAF89BDC-DC9B-46AB-B586-2206363FC66DQ36228672-641B41E0-F4C3-447D-BFDE-03CDF396EE2EQ36229199-2CEFBD45-4F76-4E60-A5B2-37FB11BA0E7DQ36242903-264904BD-0BFA-4619-9D2C-59C5B9E12AE5Q36403371-CCCD52BA-22E6-4A11-BDB0-76E8048E59A9Q36429729-5213F268-BF47-4CED-9CAF-441ABF5B5D8FQ36497982-43D1B1B8-5C3B-4FB2-B821-2A778962435DQ36518670-99CDD081-0C6A-44DE-8A3A-1F99D7675DBFQ36623081-A9CC1180-9C62-4E00-8C80-C068AC6C2711Q36670711-DF856210-48EA-4F6B-8FE7-1B188BDA1F19Q36731722-282E3F9A-4FE3-4D1A-8516-A7DA06FA6BEBQ36794899-AA585CE7-DE85-46A1-B8E1-407657ED4476Q36903442-157BF940-FB90-44C9-AF8D-02CB5D1C9BDAQ36936364-B60264F0-CBE3-4056-A7CA-F77A178F7BD4Q36958902-55EB5E71-356E-4D75-801B-D2E0A0FB365EQ37063297-C799963B-A4CD-4C06-99AF-E5E8669C4780Q37169356-36B70C35-50D7-4CB8-9EC0-F667F05C3165
P2860
Distinct contribution of IL-6, TNF-alpha, IL-1, and IL-10 to T cell-mediated spontaneous autoimmune arthritis in mice.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2004
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Distinct contribution of IL-6, ...... autoimmune arthritis in mice.
@en
Distinct contribution of IL-6, ...... autoimmune arthritis in mice.
@nl
type
label
Distinct contribution of IL-6, ...... autoimmune arthritis in mice.
@en
Distinct contribution of IL-6, ...... autoimmune arthritis in mice.
@nl
prefLabel
Distinct contribution of IL-6, ...... autoimmune arthritis in mice.
@en
Distinct contribution of IL-6, ...... autoimmune arthritis in mice.
@nl
P2093
P2860
P356
P1476
Distinct contribution of IL-6, ...... autoimmune arthritis in mice.
@en
P2093
Chieko Kanai
Eiko Moriizumi
Hiroshi Hata
Hiroyuki Yoshitomi
Kenji Sekikawa
Noriko Sakaguchi
Shimon Sakaguchi
Takashi Nakamura
Takashi Nomura
Yoichiroh Iwakura
P2860
P304
P356
10.1172/JCI200421795
P407
P577
2004-08-01T00:00:00Z